Logo-ps

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

 

 

Follower of ICMJE

Powered by:
Original Research

1. Molecular Docking Studies of Squalen Synthase Inhibitors as Potential Anti Cardiovascular Disease Drugs: Insights into Drug-Protein Interaction Discovery
Salimeh Raeisi*
Pharm Sci. 2013;19(2): 39-44.
Article
PDF
XML
Cited By:
Research Article

2. Synthesis, in Vivo and in Silico Studies of N-Aryl-4-(1,3-Dioxoisoindolin-2-Yl)Benzamides as an Anticonvulsant Agent
Parisa Kiminejad Malaie, Mehdi Asadi, Faezeh Sadat Hosseini ORCID, Mahmood Biglar, Massoud Amanlou* ORCID
Pharm Sci. 2020;26(1): 38-44. doi: 10.34172/PS.2019.54
Scopus ID: 85084609255    
Article
PDF
XML
Cited By:
4
5
Research Article

3. QSAR and Molecular Docking Studies on Non-Imidazole-Based Histamine H3 Receptor Antagonists
Maryam Hamzeh-Mivehroud ORCID, Zoha Khoshravan-Azar, Siavoush Dastmalchi* ORCID
Pharm Sci. 2020;26(2): 165-174. doi: 10.34172/PS.2019.64
Scopus ID: 85089448322    
Article
PDF
XML
Cited By:
5
6
Research Article

4. Antibacterial Components of Levisticum officinale Koch against Multidrug-resistant Mycobacterium tuberculosis
Hamidreza Monsef Esfahani, Mahdi Moridi Farimani, Samad Nejad Ebrahimi, Jee Hyung Jung, Atousa Aliahmadi, Mahdi Abbas-Mohammadi, Danielle Skropeta, Hossein Kazemian, Mohammadmehdi Feizabadi, Mansour Miran* ORCID
Pharm Sci. 2020;26(4): 441-447. doi: 10.34172/PS.2020.38
Scopus ID: 85101569876    
Article
PDF
XML
Cited By:
8
8
Research Article

5. An Epithelial Sodium Channel (ENaC)-Specific Aptamer Determined through Structure-Based Virtual Screening for the Development of Hypertension Early Detection System
Dina Ratna Komala* ORCID, Ari Hardianto ORCID, Shabarni Gaffar ORCID, Yeni Wahyuni Hartati ORCID
Pharm Sci. 2021;27(1): 67-75. doi: 10.34172/PS.2020.63
Scopus ID: 85103011356    
Article
PDF
Suppl 1
XML
Cited By:
8
3
Research Article

6. Synthesis, Anti-Inflammatory Activity and Molecular Docking Studies of 1,4,5,6-Tetrahydropyrimidine-2-Carboxamides
Volodymyr Ya. Horishny, Pavlo V. Zadorozhnii* ORCID, Ivanna V. Horishnia, Vasyl S. Matiychuk ORCID
Pharm Sci. 2021;27(3): 353-365. doi: 10.34172/PS.2020.100
Scopus ID: 85115256304    
Article
PDF
XML
Cited By:
4
4
Research Article

7. Expression, Purification and Characterization of Anti-FGF7 Domain Antibody Identified Using Phage Display Technique
Ali Akbar Alizadeh ORCID, Mona Roshani ORCID, Omid Jamshidi Kandjani ORCID, Milad Soltani-Saif ORCID, Siavoush Dastmalchi* ORCID
Pharm Sci. 2022;28(3): 405-413. doi: 10.34172/PS.2021.64
Scopus ID: 85139857307    
Article
PDF
XML
Cited By:
1
0
Research Article

8. Protective Effects of Mirazid on Gentamicin-induced Nephrotoxicity in Rats through Antioxidant, Anti-inflammatory, JNK1/ iNOS, and Apoptotic Pathways; Novel Mechanistic Insights
Samar Antar ORCID, Ahmed Ali Al-Karmalawy* ORCID, Ahmed Mourad, Magda Mourad, Mennaallah Elbadry, Sameh Saber, Ahmed Khodir*
Pharm Sci. 2022;28(4): 525-540. doi: 10.34172/PS.2022.4
Scopus ID: 85131695806    
Article
PDF
Suppl 1
XML
Cited By:
15
8
Research Article

9. In Vitro and In Silico Studies on the Anticancer and Antimicrobial Activity of Cu(II), Ni(II) and Co(II) Complexes with Bis (Pyrazolyl) Borate Derivative Ligand
Monireh Ghorbanpour ORCID, Behzad Soltani* ORCID, Ommoleila Molavi, Elnaz Mehdizadeh Aghdam
Pharm Sci. 2022;28(4): 564-571. doi: 10.34172/PS.2022.3
Scopus ID: 85136234803    
Article
PDF
XML
Cited By:
7
2
Research Article

10. Synthesis, Crystal Structure and Antibacterial Activity of Cu(II) Complex with Nitrogen Donor Pyrazolyl Borate Derivatives
Behzad Soltani* ORCID, Monireh Ghorbanpour, Saeide Bagheri, Mostafa Ebadi-Nahari, Christopher J. Ziegler
Pharm Sci. 2023;29(2): 236-245. doi: 10.34172/PS.2022.43
Scopus ID: 85150169510    
Article
PDF
XML
Cited By:
2
1
Research Article

11. Application of a Deep Eutectic Solvent for the Synthesis of Novel Imidazole-Containing Quinazoline Derivatives as Potent Cytotoxic Agents
Fatemeh Azmian Moghadam ORCID, Sara Dabirian, Amin Ebrahimi Tavani, Parisa Alipour, Mohammad Mojabi, Mehdi Evazalipour, Fatemeh Yousefbeyk, Saeed Ghasemi* ORCID
Pharm Sci. 2024;30(2): 215-228. doi: 10.34172/PS.2023.29
Scopus ID: 85189284872    
Article
PDF
XML
Cited By:
1
0
Research Article

12. Modern In Silico Molecular Docking Perspective for Investigation of Rindera lanata Bunge var. lanata targeting: Phytochemical Profile, Phytotoxicity and Bioactivity Assays
Hadi Ghanbari ORCID, Sanaz Hamedeyazdan ORCID, Reza Ghanbari ORCID, Mostafa Alilou ORCID, Abbas Delazar ORCID, Samad Nejad Ebrahimi ORCID, Amirreza Nazemiyeh, Mohammad Yousef Memar ORCID, Hossein Nazemiyeh* ORCID
Pharm Sci. 2024;30(3): 312-331. doi: 10.34172/PS.2024.5
Scopus ID: 85197799452    
Article
PDF
Suppl 1
XML
Cited By:
0
0
Research Article

13. A Lead Optimization of TOPK Inhibitors Using Complementary Computational and Synthetic Approaches
Manar Al-Sarhan ORCID, Lara I. Fakhouri* ORCID, Nizar A. Al‑Shar’i* ORCID, Tamam El-Elimat, Aref Zayed
Pharm Sci. 2024;30(4): 456-468. doi: 10.34172/PS.2024.20
Scopus ID: 85205802955    
Article
PDF
Suppl 1
XML
Cited By:
0
0

   Indexing & Abstracting: